Hemington Wealth Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$0 Buy
26
+4
+18% +$115 ﹤0.01% 1738
2025
Q2
$0 Sell
22
-6
-21% -$174 ﹤0.01% 1727
2025
Q1
$0 Buy
28
+14
+100% +$534 ﹤0.01% 1771
2024
Q4
$0 Buy
14
+10
+250% +$379 ﹤0.01% 1802
2024
Q3
$0 Buy
+4
New +$113 ﹤0.01% 1759

Other funds holding VCYT

Hemington Wealth Management's VCYT Position: Q3 2025 in Review

Hemington Wealth Management increased its Veracyte (VCYT) stake by 18% in Q3 2025, buying an estimated $115 and bringing the position to 26 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1738.

Hemington Wealth Management first reported a position in VCYT in Q3 2024 and has held it in 5 quarters since. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

  • Hemington Wealth Management held 26 shares of Veracyte worth $0 as of Q3 2025.
  • Hemington Wealth Management bought 4 Veracyte shares in Q3 2025, an estimated $115.
  • Veracyte made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1738 holding.
  • Hemington Wealth Management first reported a position in Veracyte in Q3 2024 and has held it in 5 quarters since.
  • 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.